Analysis of Clinical Outcome of Patients with Poorly Differentiated Thyroid Carcinoma

Table 2

The clinical characteristics of patients with focal and diffuse component of PDTC.

		Focal component	Diffuse component	𝑃 value
Number		15	14	—
Gender (M/F)		4/15	7/14	n.s.
Age (median; range)		57 (20–71)	58 (22–83)	n.s.
Tumor size (cm)		2.7571.4	3.3972.1	n.s.
Ex*1	0	9	4	𝑃<.01
	1	5	2
	2	1	8
Lymph node involvement*2	0	5	3	n.s.
	1a	8	7
	1b	2	4
Pathological subtypes	Solid	4	3	n.s.
	Insular	2	3
	Trabecular	4	2
	Solid & trabecular	5	4
Local recurrence	P	4	5	n.s.
	N	11	9
Distant recurrence	P	1	2	n.s.
	N	14	12

P: positive, N: negative
*1 EX1: infiltrating to adjacent muscle and/or fat tissue, EX2: infiltrating to adjacent organs such as trachea, esophagus, and so forth.
*2 1a: central cervical lymph node involvement, 1b: lateral cervical lymphnode involvement.